The Latest Breaking News from Medicaid

President Joe Biden is under pressure to preserve access to abortion, but he has few good options to do it

Centene Corporation (NYSE:CNC) has agreed to sell Magellan Rx to Prime Therapeutics LLC and PANTHERx Rare to a consortium of The Vistria Group, General Atlantic, and Nautic Partners.  Centene expects to receive approximately $2.8 billion in aggregate proceeds from the transactions. Magellan Rx is a comprehensive pharmacy solutions organization with specialty drug management, Medicaid administration, and comprehensive pharmacy…

For the first time, the U.S. came close to providing health care for all for the first time during the coronavirus pandemic

Liberal policymakers are quickly positioning their states as abortion havens after a leaked draft of a U.S. Supreme Court opinion indicating that the court could overturn Roe v. Wade was made public on the evening of May 2, 2022.

Home health care workers are among the lowest paid, shifting the burden of long-term care to aging and overstressed family members or assisted living centers, which are often understaffed themselves.

In South Dakota, two separate campaigns submitted their petition signatures on May 3 to get their initiatives on the ballot in November. The signatures were submitted to the secretary of state’s office on Tuesday afternoon.

A draft Supreme Court opinion suggesting the right to abortion will be overturned is highlighting the risk to Black and Hispanic women

Under current Supreme Court precedent, the answer is probably "yes." But that precedent might not hold, thanks in part to Clarence Thomas.

The Catholic hospital system that runs Franciscan Health Hammond closed Franciscan St. James Health in Chicago Heights in 2018, also citing low demand for inpatient care even as it’s built new hospitals in wealthier suburbs.

SACRAMENTO, Calif. — California is still offering free COVID-19 testing to uninsured residents even though the federal government ran out of money to pay for it.

Centene Corporation (NYSE:CNC) has reported a Q1 FY22 adjusted EPS of $1.83, compared to $1.63 a year ago, beating the consensus estimate of $1.68. Sales increased 24% Y/Y to $37.18 billion, beating the consensus of $34.50 billion. Health Benefits Ratio of 87.3%, up from 86.8% a year ago, due to a return…